Exelixis | Capitalisation Boursière



Market Capitalization Changement Date
Acadia Pharmaceuticals USD 2.46B 312M 2025-04
Agios Pharmaceuticals USD 1.57B 303M 2025-04
Amgen USD 155.38B 15.41B 2025-04
AstraZeneca GBP 157.7B 4.61B 2025-04
Bayer EUR 20.62B 1.09B 2025-04
BioMarin Pharmaceutical USD 11.34B 1.19B 2025-04
Bristol-Myers Squibb USD 100.66B 14.06B 2025-04
Cytokinetics USD 4.49B 1.06B 2025-04
Eisai JPY 1.1T 165.68B 2025-04
Eli Lilly USD 706.59B 26.28B 2025-04
Exelixis USD 10.33B 1000K 2025-04
Genmab DKK 82.03B 16.76B 2025-04
Glaxosmithkline USD 73.89B 4.07B 2025-04
Incyte USD 13.05B 253M 2025-04
Ionis Pharmaceuticals USD 4.15B 1.37B 2025-04
MacroGenics USD 76M 4M 2025-04
Merck USD 196.74B 54.91B 2025-04
Moderna USD 9.83B 6.17B 2025-04
Neurocrine Biosciences USD 9.87B 3.95B 2025-04
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 126.33B 24.01B 2025-04
Takeda JPY 6.61T 2.95B 2025-04
Ultragenyx Pharmaceutical USD 2.86B 1.03B 2025-04
Xencor USD 568M 1.04B 2025-04



Exelixis Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.